Onyx Overview

  • Year Founded
  • 2024

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $8M

  • Investors
  • 4

Onyx General Information

Description

Developer of a biological research platform designed to model human immune responses to infections, inflammation, and medical treatments through longitudinal data collection and analysis. The company offers in-house laboratory processing, single-cell transcriptomics, immune receptor tracking, proteomics, metabolomics, genomics, and participant-level clinical data, enabling biopharmaceutical companies and artificial intelligence research teams to study complex biological processes, identify therapeutic targets, develop medicines, and select suitable participants for clinical trials.

Contact Information

Website
www.onyx.bio
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 626 Bancroft Way
  • Suite A
  • Berkeley, CA
  • United States
+1 (415)
Primary Industry
Biotechnology
Other Industries
Discovery Tools (Healthcare)
Corporate Office
  • 626 Bancroft Way
  • Suite A
  • Berkeley, CA
  • United States
+1 (415)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Onyx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC 08-Oct-2026 $8M Completed Generating Revenue
To view Onyx’s complete valuation and funding history, request access »

Onyx Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a biological research platform designed to model human immune responses to infections, inflammation, and me
Biotechnology
Berkeley, CA
10 As of 2026

Rockville, MD
 

Niel, Belgium
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Onyx Competitors (18)

One of Onyx’s 18 competitors is Regenxbio, a Formerly VC-backed company based in Rockville, MD.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Regenxbio Formerly VC-backed Rockville, MD
etherna Formerly VC-backed Niel, Belgium
Adaptimmune Therapeutics Formerly VC-backed Abingdon, United Kingdom
Intellia Therapeutics Formerly VC-backed Cambridge, MA
CytomX Therapeutics Formerly VC-backed South San Francisco, CA
You’re viewing 5 of 18 competitors. Get the full list »

Onyx Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Onyx Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Dimension Capital Management Corporation Minority
Haystack Management Company Venture Capital Minority
Refactor Capital Venture Capital Minority
Standard Crypto Venture Capital Minority
To view Onyx’s complete investors history, request access »

Onyx FAQs

  • When was Onyx founded?

    Onyx was founded in 2024.

  • Where is Onyx headquartered?

    Onyx is headquartered in Berkeley, CA.

  • What is the size of Onyx?

    Onyx has 10 total employees.

  • What industry is Onyx in?

    Onyx’s primary industry is Biotechnology.

  • Is Onyx a private or public company?

    Onyx is a Private company.

  • What is Onyx’s current revenue?

    The current revenue for Onyx is .

  • How much funding has Onyx raised over time?

    Onyx has raised $8M.

  • Who are Onyx’s investors?

    Dimension Capital Management, Haystack Management Company, Refactor Capital, and Standard Crypto have invested in Onyx.

  • Who are Onyx’s competitors?

    Regenxbio, etherna, Adaptimmune Therapeutics, Intellia Therapeutics, and CytomX Therapeutics are some of the 18 competitors of Onyx.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process